These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36199414)

  • 1. Assessment of dengue virus inactivation in random donor platelets using amotosalen and ultraviolet A illumination.
    Kumar A; Tiwari AK; Kumar S; Biswas A; Singh G; Chatterjee K; Chakroborty S; Sunil S
    Asian J Transfus Sci; 2022; 16(1):67-72. PubMed ID: 36199414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination.
    Musso D; Richard V; Broult J; Cao-Lormeau VM
    Transfusion; 2014 Nov; 54(11):2924-30. PubMed ID: 24845685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.
    Santa Maria F; Laughhunn A; Lanteri MC; Aubry M; Musso D; Stassinopoulos A
    Transfusion; 2017 Aug; 57(8):2016-2025. PubMed ID: 28671343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light.
    Hindawi SI; El-Kafrawy SA; Hassan AM; Badawi MA; Bayoumi MM; Almalki AA; Zowawi HM; Tolah AM; Alandijany TA; Abunada Q; Picard-Maureau M; Damanhouri GA; Azhar EI
    Transfus Clin Biol; 2022 Feb; 29(1):31-36. PubMed ID: 34411748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
    Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
    Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bacterial inactivation in random donor platelets and single-donor apheresis platelets by the INTERCEPT blood system.
    Makroo RN; Sardana R; Mediratta L; Butta H; Thakur UK; Agrawal S; Chowdhry M; Kumar S; Chokroborty S
    Asian J Transfus Sci; 2018; 12(2):146-153. PubMed ID: 30692800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
    BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione.
    Laughhunn A; Huang YS; Vanlandingham DL; Lanteri MC; Stassinopoulos A
    Transfusion; 2018 Mar; 58(3):748-757. PubMed ID: 29322519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion model.
    Slichter SJ; Bailey SL; Gettinger I; Pellham E; Christoffel T; Castro G; Green JM; Stassinopoulos A
    Vox Sang; 2019 Aug; 114(6):595-604. PubMed ID: 31297836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione.
    Aubry M; Laughhunn A; Santa Maria F; Lanteri MC; Stassinopoulos A; Musso D
    Transfusion; 2017 Dec; 57(12):2888-2896. PubMed ID: 28921542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.
    Thiele T; Sablewski A; Iuga C; Bakchoul T; Bente A; Görg S; Völker U; Greinacher A; Steil L
    Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s63-70. PubMed ID: 22890270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen-reduction technology.
    Girard YA; Santa Maria F; Lanteri MC
    Transfusion; 2020 Mar; 60(3):622-627. PubMed ID: 31957887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
    Azhar EI; Hindawi SI; El-Kafrawy SA; Hassan AM; Tolah AM; Alandijany TA; Bajrai LH; Damanhouri GA
    Vox Sang; 2021 Jul; 116(6):673-681. PubMed ID: 33277935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination.
    Aubry M; Richard V; Green J; Broult J; Musso D
    Transfusion; 2016 Jan; 56(1):33-40. PubMed ID: 26283013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
    Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
    Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.
    Lanteri MC; Santa-Maria F; Laughhunn A; Girard YA; Picard-Maureau M; Payrat JM; Irsch J; Stassinopoulos A; Bringmann P
    Transfusion; 2020 Jun; 60(6):1319-1331. PubMed ID: 32333396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
    Lin L; Conlan MG; Tessman J; Cimino G; Porter S
    Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates.
    Muret C; Crettaz D; Alberio L; Prudent M
    Transfus Med Hemother; 2024 Apr; 51(2):101-110. PubMed ID: 38584699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.